A distinguished leader with distinctive vision FUTURA SURGICARE PVT. LTD.

Businesses nowadays are in constant quest of developing ‘bleeding edge’, ‘silver bullets’, or ‘reinventing the wheels’. Many ventures succeed in this endeavor whereas several fail to do so. Well be it the success of any endeavor or its failure, it depends on many factors where proper bandwidth is one such aspect. Futura Surgicare has undeniably carved a niche for itself with its spectacular breakthroughs as one of the leading manufacturers of wound closure products in India. As a family-owned business that began its journey back in 1994, the organisation happened to offer a diverse range of relatable products under the brands Dolphin Sutures, Dolphin Mesh, Dolphin Stapler, Dolphin Hemostat & Dolphin Tapes.

Mr A.D Setty is the founding head of the company and has been spearheading his venture through thick and thin based on his years of extensive experience in the industry. What is noteworthy here is the fact that under his guidance, the company has gained traction and added substantial value to people at ground level. Keeping up with the customer pulse and market demands, he happened to develop products that spoke the most to people in dire need of such offerings. Needless to mention, the company has managed to stay ahead of the competition by thoroughly studying the market and developing the products to cater to the present market dynamics. Many of the top surgeons in India as well as overseas are in close collaboration with Futura Surgicare that helps it get a better understanding of the market requirements. The company’s vision is to become the surgeons’ foremost choice for safe and secure wound closure.

We had a face-to-face meeting with Mr. Abhijith Sagar, the company’s Director. He holds an MBA with a marketing concentration and has worked in the field for 15 years and also serves as the company’s R&D division’s director. He shed light on the company’s different aspects to enlighten us with vision, mission, product portfolio,etc. Trimming the fat, let’s dive in-

The key to successInnovation

As per the CEO, innovation always poses as the key to success. For Futura Surgicare, innovation has ensured a sure success. Today, it has been well-acclaimed for its largest range of Antibacterial Sutures that have offered them global repute. Following its innovative streak, the leader supervised the launch of different unique products in the Hernia repairing space. Now, they own the largest portfolio of composite meshes that offers adhesion barrier and better biocompatibility- giving a leading edge to their portfolio. He happened to explain that Indian manufacturers must go above and beyond to win customers’ trust in a nation like India, where more than 80% of all medical equipment is still imported. This is especially true when dealing with a very delicate product like surgical sutures. Creating Dolphin Sutures was the same. Up until the brand became well-known, they had to earn the trust of the client by constantly delivering high-quality goods and services. They were able to get through this challenging time based on patience and perseverance.

Winning the clientage

The Wound Closure division is the company’s primary emphasis. The business closely collaborates with customers in this market to comprehend their wants and create items that meet those objectives. Sutures, staplers, surgical tapes, and topical skin adhesives are now available from the company’s comprehensive line of wound closure products. Fortis, Manipal Hospitals, AIIMS, and others are just a few of its prestigious clients. Additionally, the business exports its goods to approximately 65 nations, mostly in Europe, Asia, and Africa.

The leadership team is very much into keeping its clientele highly satisfied and ensures to maintain a high customer satisfaction rate. The business has never compromised on the quality, procedures, or commitments it has made to its clients and staff. It has undergone several certifications, including CE, ISO 13485, ISO 9001, and WHO:GMP, as proof of this. Additionally, the business is the only suture maker in India that has earned the strict ICMED 9000 and ICMED 13485 quality certifications for Indian-made medical equipment.

Synergy with R&D and technology

For Futura Surgicare Pvt. Ltd, R&D is crucial to create a new productline that could meet the expectation of the targeted customer base. Abhijith team has introduced a number of distinctive items for the first time in the nation.

In the hunt for the newest technology, the corporation seizes the lead. It was the first firm in India to release Durabarb, a Knotless wound closure device. It is the sole business producing the ground-breaking Teflene sutures made of PTFE

Cultivating an exciting workforce

Workforce is the backbone of any thriving company and a positive work environment is essential to scale the ladder of success. The staff at the organisation is extremely skilled and devoted. One of the secrets to the success of the company is that employee turnover is less than 5% throughout the whole organisation. They also show how consistently the business upholds its principles, rules and ethics.

Golden feathers in the cap

Under the stewardship of Abhijith, the company has crossed several milestones and bagged different accolades & recognitions. A few of the worthy mentions are as follows-

• In 1997, it became the first company to launch PGA sutures in India

• In 2007, it happened to emerge as the first Indian company to launch Polyglactin 910 sutures

• In 2008, it has achieved CE certification for the first time

• In 2010, it became the first Indian company to launch Poliglecaprone & Polydioxanone sutures

• In 2012, it was the first Indian company to launch Antibacterial Triclosan Coated sutures

• In 2013-18, it launched skin staplers, hernia meshes, skin staplers, bone wax, etc.

• In 2019, it became the first Indian company to launch Barb sutures – knotless wound closure device

• In 2021, it launched PTFE Sutures, 6 Composite Meshes for the 1st time in India

• In 2022, it introduced Topical Skin Adhesives, Hemostats and 5 types of antibacterial sutures- the world’s largest Antibacterial Suture Portfolio.

For the future, Abhijith has planned to expand the product basket of the company along with the sales team. Also, a sheer focus would be on the export market too. He envisions spreading the company’s reach across 100 countries by the end of 2025.